Your browser doesn't support javascript.
loading
Time to Confirmatory Study Initiation After Accelerated Approval of Cancer and Noncancer Drugs in the US.
Jazowski, Shelley A; Vaidya, Avi U; Donohue, Julie M; Dusetzina, Stacie B; Sachs, Rachel E.
Affiliation
  • Jazowski SA; Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Vaidya AU; Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Donohue JM; Department of Health Policy and Management, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.
  • Dusetzina SB; Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Sachs RE; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
JAMA Intern Med ; 183(7): 737-739, 2023 07 01.
Article in En | MEDLINE | ID: mdl-37213097
This cross-sectional study examines and compares the time taken from the accelerated approval of cancer and noncancer drugs to the initiation of confirmatory studies in the US.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Type of study: Observational_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: JAMA Intern Med Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Type of study: Observational_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: JAMA Intern Med Year: 2023 Document type: Article